FDA product code QYE: Reduced Ejection Fraction Machine Learning-Based Notification Software
QYE is the FDA product code for reduced ejection fraction machine learning-based notification software. It is a Class II device, regulated under 21 CFR 870.2380 and reviewed by the Cardiovascular panel. FDA has cleared 7 510(k) submissions under QYE, 7 in the last five years, from 6 different applicants. The average 510(k) review took 180 days (median 180); 206 days on average over the last three years.
Definition
Reduced Ejection Fraction machine learning-based notification software employs machine learning techniques to suggest the likelihood of a reduced ejection fraction for further referral or diagnostic follow-up.
Classification
| Field | Value |
|---|---|
| Device name | Reduced Ejection Fraction Machine Learning-Based Notification Software |
| Device class | Class II |
| Regulation | 21 CFR 870.2380 |
| Review panel | CV — Cardiovascular |
| Medical specialty | Cardiovascular |
| Premarket route | 510(k) |
510(k) clearances per year for QYE
| Year | Clearances | Avg. review days |
|---|---|---|
| 2023 | 1 | 23 |
| 2024 | 1 | 174 |
| 2025 | 3 | 175 |
| 2026 | 2 | 270 |
Compare with all 510(k) review times · Search every QYE clearance
Top QYE applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Anumana, Inc. | 2 | 2025-07-28 |
| ARPI, Inc. | 1 | 2026-11-06 |
| Medical AI Co., Ltd. | 1 | 2026-09-30 |
| BunkerHill Health | 1 | 2025-09-19 |
| Tempus AI, Inc. | 1 | 2025-07-15 |
1 more applicants have QYE clearances. See the full list in Caduvo.
Most recent QYE clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K260436 | ARPI, Inc. | ECG Buddy-LVD (EB-LVD-01) | 2026-11-06 | 268 |
| K254302 | Medical AI Co., Ltd. | ECG Analysis Software (AiTiALVSD) | 2026-09-30 | 273 |
| K250649 | BunkerHill Health | Bunkerhill ECG-EF | 2025-09-19 | 199 |
| K250652 | Anumana, Inc. | ECG-AI Low Ejection Fraction (LEF) 12-Lead algorithm (1010) | 2025-07-28 | 146 |
| K250119 | Tempus AI, Inc. | Tempus ECG-Low EF | 2025-07-15 | 180 |
Recalls for QYE devices
FDA recall records list no recalls for product code QYE.
Frequently asked questions
What is FDA product code QYE?
QYE is the FDA product code for reduced ejection fraction machine learning-based notification software. It is a Class II device, regulated under 21 CFR 870.2380 and reviewed by the Cardiovascular panel.
What device class is QYE?
Class II, regulation 21 CFR 870.2380. Typical premarket route: 510(k).
How long does a 510(k) take for product code QYE?
Across 7 cleared submissions the average was 180 days from receipt to decision (median 180).
Which companies have the most QYE clearances?
Anumana, Inc. (2); ARPI, Inc. (1); Medical AI Co., Ltd. (1); BunkerHill Health (1); Tempus AI, Inc. (1).
Next steps
- Run an FDA pathway report with predicate devices for product code QYE
- Run a recall and safety report across every QYE manufacturer
- Watch product code QYE for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Cardiovascular product codes · FDA product code lookup · 510(k) database search · 510(k) review times